BAL PHARMA LTD. Financial Ratios
BALPHARMA · Healthcare · Current price ₹85.59
P/E ratio
21.7x
P/B ratio
1.5x
ROE
7.9%
ROCE
10.0%
Debt / Equity
1.48
Dividend yield
1.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 21.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 7.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 10.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.48 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with BAL PHARMA LTD.'s latest numbers.
BAL PHARMA LTD. profitability
BAL PHARMA LTD. generates a return on equity of 7.9% and a return on capital employed of 10.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.48 and a P/E of 21.7x, BAL PHARMA LTD. is moderately leveraged. Our overall business-quality score for the company is 3.2 / 10.
Understand the ratios
More on BAL PHARMA LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.